Through constant research and innovation, based on ethics and a responsible attitude, we seek to consolidate the leadership of our biosimilar products, from Active Pharmaceutical Ingredient to Finished Dosage Form.
This new vision enables AMEGA Biotech to access markets such as Latin America, MENA, Turkey, Southeast Asia, Russia, Ukraine.
In AMEGA Biotech we are based on four values that define the way we work and the way we interact, at a professional and personal level, both inside and outside the company: adaptability, innovation, commitment, personal development.
We adapt to change and market needs, using the necessary resources to achieve our objectives.
We are committed to acting responsibly and ethically in all our actions, in our relationships with customers, suppliers, colleagues, the social community and the environment
Each of our products was developed and produced by innovative technology but, above all, by enthusiastic and inspiring people.
In order to achieve full development of our people, we encourage trust and good relations as the basis for achieving a sound and attractive environment making working days enjoyable.
Our organization has set precedent for a dynamic development model that is able to control all the processes in the biopharmaceutical production chain as well as quality assurance, from the Active Pharmaceutical Ingredient (API) to the Finished Dosage Form (FDF).
AMEGA Biotech combines the best-qualited professionals and scientists in the field and designs skillful and creative working teams that share our vision and values. This highly qualited resource is the key engine in our contribution to biotechnology and in our pursuit of improving people’s quality of life.
Our team includes experienced scientists, many of which are bearing PhD degrees. Their solid trajectory certifies the expertise in a broad range of cell cultures such as CHO, E-coli, BHK and yeast cells.